{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T19:33:34Z","timestamp":1781897614546,"version":"3.54.5"},"reference-count":206,"publisher":"Informa UK Limited","issue":"3","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Clinical Immunology"],"published-print":{"date-parts":[[2021,3,4]]},"DOI":"10.1080\/1744666x.2021.1880895","type":"journal-article","created":{"date-parts":[[2021,1,23]],"date-time":"2021-01-23T01:13:15Z","timestamp":1611364395000},"page":"209-223","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":22,"title":["Chimeric antigen receptor T-cell therapy for melanoma"],"prefix":"10.1080","volume":"17","author":[{"given":"Azadehsadat","family":"Razavi","sequence":"first","affiliation":[{"name":"Department of Animal Biology, Faculty of Biology Sciences, University of Kharazmi, Tehran, Iran"},{"name":"Cancer Immunology Project (CIP), Universal Scientific Education and Research Network (USERN), Tehran, Iran"},{"name":"Research Center for Immunodeficiencies, Children\u2019s Medical Center, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8226-5878","authenticated-orcid":false,"given":"Mahsa","family":"Keshavarz-Fathi","sequence":"additional","affiliation":[{"name":"Cancer Immunology Project (CIP), Universal Scientific Education and Research Network (USERN), Tehran, Iran"},{"name":"School of Medicine, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Pawelek","sequence":"additional","affiliation":[{"name":"Department of Dermatology and the Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nima","family":"Rezaei","sequence":"additional","affiliation":[{"name":"Research Center for Immunodeficiencies, Children\u2019s Medical Center, Tehran University of Medical Sciences, Tehran, Iran"},{"name":"Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran"},{"name":"Cancer Immunology Project (CIP), Universal Scientific Education and Research Network (USERN), Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,1,31]]},"reference":[{"issue":"2","key":"cit0001","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/gcc.20728","volume":"49","author":"Degenhardt Y","year":"2010","journal-title":"Genes Chromosomes Cancer"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.5114\/pdia.2013.33376"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcsup.2013.07.012"},{"key":"cit0004","doi-asserted-by":"crossref","unstructured":"Bandarchi B, Ma L, Navab R, et al. From melanocyte to metastatic malignant melanoma. Dermatol Res Pract. 2010;2010:583748.","DOI":"10.1155\/2010\/583748"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1002\/path.5213"},{"issue":"6","key":"cit0006","first-page":"1005","volume":"28","author":"Rastrelli M","year":"2014","journal-title":"In Vivo"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1002\/em.22176"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1562\/0031-8655(2002)076<0664:UESOS>2.0.CO;2"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2005.04.038"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-22539-5_2"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.29050"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12492"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1007\/s10552-005-3637-4"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.1203"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/93.9.678"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2011.04.032"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1177\/120347540300700601"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)09779-9"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22126"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.21836"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.08029.x"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.11360"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-016-2438-3"},{"key":"cit0024","volume-title":"Epidemiology of melanoma. Cutaneous melanoma: etiology and therapy [Internet]","author":"Matthews NH","year":"2017"},{"issue":"6","key":"cit0025","first-page":"488","volume":"23","author":"Bhatia S","year":"2009","journal-title":"Oncology (Williston Park)"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.01.025"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.01381"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2018.08.011"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1016\/j.jphotobiol.2019.111737"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-017-0575-8"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1002\/mc.23148"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/5245034"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaa4967"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-015-1767-4"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1016\/bs.ircmb.2018.05.010"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-017-0230-9"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2013.154"},{"issue":"2","key":"cit0038","doi-asserted-by":"crossref","DOI":"10.1002\/1097-0142(20010715)92:2<369::AID-CNCR1332>3.0.CO;2-U","volume":"92","author":"Ugurel S","year":"2001","journal-title":"Cancer: Interdisciplinary International Journal of the American Cancer Society"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.2217\/imt.14.123"},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-018-0325-1"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00351"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20246223"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12773"},{"key":"cit0044","doi-asserted-by":"crossref","unstructured":"Wei J, Han X, Bo J, et al. Target selection for CAR-T therapy. J Hematol Oncol. 2019;12(1):62.","DOI":"10.1186\/s13045-019-0758-x"},{"key":"cit0045","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(97)70144-0"},{"key":"cit0046","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-197206010-00010"},{"key":"cit0047","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(80)90201-1"},{"key":"cit0048","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.1356"},{"key":"cit0049","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2015.00135"},{"issue":"2","key":"cit0050","first-page":"141","volume":"61","author":"Sabel MS","year":"2006","journal-title":"Minerva Chir"},{"key":"cit0051","doi-asserted-by":"publisher","DOI":"10.2217\/mmt-2019-0015"},{"key":"cit0052","doi-asserted-by":"publisher","DOI":"10.1002\/jso.20303"},{"key":"cit0053","doi-asserted-by":"publisher","DOI":"10.1097\/00008390-199812000-00010"},{"key":"cit0054","doi-asserted-by":"publisher","DOI":"10.1186\/1748-717X-6-12"},{"key":"cit0055","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198210073071503"},{"key":"cit0056","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9610(98)00041-5"},{"key":"cit0057","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-6-53"},{"issue":"1483","key":"cit0058","volume":"9","author":"Silk AW","year":"2020","journal-title":"Frontiers in Oncology"},{"key":"cit0059","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-014-0277-5"},{"key":"cit0060","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-22539-5_8"},{"key":"cit0061","doi-asserted-by":"publisher","DOI":"10.1016\/j.dnarep.2015.04.002"},{"key":"cit0062","doi-asserted-by":"publisher","DOI":"10.1097\/00008390-199510000-00010"},{"key":"cit0063","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19891115)64:10<2024::AID-CNCR2820641010>3.0.CO;2-V"},{"key":"cit0064","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2007.25.18_suppl.8510"},{"key":"cit0065","doi-asserted-by":"publisher","DOI":"10.1097\/PPO.0000000000000024"},{"key":"cit0066","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.annonc.a010762"},{"key":"cit0067","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.2001.1731"},{"key":"cit0068","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.01.1551"},{"key":"cit0069","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.10.2822"},{"key":"cit0070","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-0116"},{"key":"cit0071","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1302369"},{"key":"cit0072","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)60898-4"},{"issue":"5","key":"cit0073","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1200\/JCO.1998.16.5.1743","volume":"16","author":"Falkson CI","year":"1998","journal-title":"J clin oncol"},{"key":"cit0074","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.3.968"},{"key":"cit0075","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.20.6.1600"},{"key":"cit0076","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1987.5.4.574"},{"key":"cit0077","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.b19-00976"},{"key":"cit0078","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11921"},{"issue":"1","key":"cit0079","first-page":"1","volume":"44","author":"Strojan PJR","year":"2010","journal-title":"Role of Radiotherapy in Melanoma Management"},{"key":"cit0080","doi-asserted-by":"publisher","DOI":"10.2478\/v10019-010-0008-x"},{"key":"cit0081","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-019-1426-6"},{"key":"cit0082","doi-asserted-by":"publisher","DOI":"10.3857\/roj.2019.00437"},{"key":"cit0083","doi-asserted-by":"crossref","unstructured":"Park S, Lee WJ, Park S, et al. Reversibly pH-responsive gold nanoparticles and their applications for photothermal cancer therapy. Sci Rep. 2019;9(1):1\u20139.","DOI":"10.1038\/s41598-019-56754-8"},{"key":"cit0084","doi-asserted-by":"publisher","DOI":"10.2217\/imt.15.65"},{"key":"cit0085","doi-asserted-by":"publisher","DOI":"10.1016\/j.suc.2019.09.010"},{"key":"cit0086","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2016.07.145"},{"key":"cit0087","doi-asserted-by":"publisher","DOI":"10.1245\/ASO.2005.03.536"},{"key":"cit0088","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-17-0314"},{"key":"cit0089","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cgt.7700441"},{"issue":"2","key":"cit0090","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/1097-0142(20010715)92:2<369::AID-CNCR1332>3.0.CO;2-U","volume":"92","author":"Ugurel S","year":"2001","journal-title":"Cancer: Interdiscip Int J Am Cancer Soc"},{"key":"cit0091","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1406498"},{"key":"cit0092","doi-asserted-by":"publisher","DOI":"10.1111\/pcmr.12340"},{"key":"cit0093","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-012-1371-9"},{"key":"cit0094","doi-asserted-by":"publisher","DOI":"10.1097\/00002371-200007000-00006"},{"key":"cit0095","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2014.42"},{"key":"cit0096","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-14-0167"},{"key":"cit0097","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-004-0575-z"},{"key":"cit0098","first-page":"12","volume":"11","author":"Wang JJ","year":"2019","journal-title":"Cureus"},{"key":"cit0099","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-019-0522-3"},{"key":"cit0100","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(93)70011-H"},{"key":"cit0101","doi-asserted-by":"crossref","unstructured":"Curti B, Crittenden M, Seung SK, et al. Randomized phase II study of stereotactic body radiotherapy and interleukin-2 versus interleukin-2 in patients with metastatic melanoma. J Immunother Cancer. 2020;8:1.","DOI":"10.1136\/jitc-2020-000773"},{"key":"cit0102","doi-asserted-by":"crossref","unstructured":"Trinh VA, Zobniw C, Hwu W-J. The efficacy and safety of adjuvant interferon-alfa therapy in the evolving treatment landscape for resected high-risk melanoma. Expert Opin Drug Saf. 2017;16(8):933\u2013940.","DOI":"10.1080\/14740338.2017.1343301"},{"key":"cit0103","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2015.02.018"},{"key":"cit0104","doi-asserted-by":"publisher","DOI":"10.1007\/82_2017_61"},{"key":"cit0105","unstructured":"Weber JS, O\u2019Day S, Urba W, et al. Phase I\/II study of ipilimumab for patients with metastatic melanoma. J Clin Oncol.\u00a0 2008;26(36):5950\u20135956."},{"key":"cit0106","doi-asserted-by":"crossref","unstructured":"Camacho LH, Antonia S, Sosman J, et al. Phase I\/II trial of tremelimumab in patients with metastatic melanoma. J Clin Oncol. 2009;27(7):1075\u20131081.","DOI":"10.1200\/JCO.2008.19.2435"},{"key":"cit0107","doi-asserted-by":"crossref","unstructured":"Callahan MK, Kluger H, Postow MA, et al. Nivolumab plus ipilimumab in patients with advanced melanoma: updated survival, response, and safety data in a phase I dose-escalation study. J Clin Oncol. 2018;36(4):391.","DOI":"10.1200\/JCO.2017.72.2850"},{"key":"cit0108","doi-asserted-by":"crossref","unstructured":"Banaszynski M, Kolesar J-S. Vemurafenib and ipilimumab: new agents for metastatic melanoma. Am J Health Syst Pharm. 2013;70(14):1205\u20131210.","DOI":"10.2146\/ajhp120260"},{"key":"cit0109","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1003466"},{"key":"cit0110","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60958-2"},{"key":"cit0111","first-page":"16(4):375-384","author":"Weber JS","year":"2015","journal-title":"Lancet Oncol"},{"key":"cit0112","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez-Cerdeira C, Carnero Gregorio M, L\u00f3pez-Barcenas A, et al. Advances in immunotherapy for melanoma: a comprehensive review. 2017;2017:3264217.","DOI":"10.1155\/2017\/3264217"},{"key":"cit0113","doi-asserted-by":"publisher","DOI":"10.1097\/CJI.0b013e3181ee7095"},{"key":"cit0114","doi-asserted-by":"crossref","unstructured":"Peng W, Williams LJ, Xu C, et al. Anti-OX40 antibody directly enhances the function of tumor-reactive CD8+ T cells and synergizes with PI3K\u03b2 inhibition in PTEN loss melanoma. Clin Cancer Res. 2019;25(21):6406\u20136416.","DOI":"10.1158\/1078-0432.CCR-19-1259"},{"key":"cit0115","doi-asserted-by":"crossref","unstructured":"Kvarnhammar AM, Veitonm\u00e4ki N, H\u00e4gerbrand K, et al. The CTLA-4 x OX40 bispecific antibody ATOR-1015 induces anti-tumor effects through tumor-directed immune activation. J Immunother Cancer. 2019;7(1):1\u201314.","DOI":"10.1186\/s40425-019-0570-8"},{"key":"cit0116","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-407190-2.00007-1"},{"key":"cit0117","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1012863"},{"key":"cit0118","doi-asserted-by":"crossref","unstructured":"Butterfield LH, Vujanovic L, Santos PM, et al. Multiple antigen-engineered DC vaccines with or without IFN\u03b1 to promote antitumor immunity in melanoma. J Immunother Cancer. 2019;7(1):113.","DOI":"10.1186\/s40425-019-0552-x"},{"issue":"109966","key":"cit0119","volume":"125","author":"Sheng L","year":"2020","journal-title":"Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie"},{"key":"cit0120","doi-asserted-by":"publisher","DOI":"10.1172\/JCI87624"},{"key":"cit0121","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01993"},{"key":"cit0122","doi-asserted-by":"publisher","DOI":"10.1002\/jso.23481"},{"key":"cit0123","first-page":"S11","volume":"6","author":"Atkins MB","year":"2000","journal-title":"The Cancer Journal from Scientific American"},{"key":"cit0124","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2005.23.16_suppl.7543"},{"key":"cit0125","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S171693"},{"key":"cit0126","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx079"},{"key":"cit0127","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1003466"},{"key":"cit0128","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1412082"},{"key":"cit0129","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31892"},{"key":"cit0130","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-018-0459-y"},{"key":"cit0131","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-016-3237-x"},{"issue":"1","key":"cit0132","first-page":"31","volume":"66","author":"Al-Sarraf M","year":"1982","journal-title":"Cancer Treat Rep"},{"issue":"2","key":"cit0133","first-page":"171","volume":"71","author":"Evans LM","year":"1987","journal-title":"Cancer Treat Rep"},{"key":"cit0134","doi-asserted-by":"publisher","DOI":"10.1097\/CMR.0000000000000509"},{"key":"cit0135","doi-asserted-by":"publisher","DOI":"10.1007\/s11523-020-00695-0"},{"key":"cit0136","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.27304"},{"key":"cit0137","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1203421"},{"key":"cit0138","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1103782"},{"key":"cit0139","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13174"},{"key":"cit0140","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-11-2837"},{"key":"cit0141","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-10-0043"},{"key":"cit0142","doi-asserted-by":"publisher","DOI":"10.5041\/RMMJ.10179"},{"key":"cit0143","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-10-169"},{"key":"cit0144","doi-asserted-by":"crossref","unstructured":"Dudley ME, Wunderlich JR, Shelton TE, et al. Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients. J Immunother. 2003;26(4):332.","DOI":"10.1097\/00002371-200307000-00005"},{"key":"cit0145","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2018.1476816"},{"key":"cit0146","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2014.12.009"},{"key":"cit0147","doi-asserted-by":"publisher","DOI":"10.1097\/01.cji.0000211321.07654.b8"},{"key":"cit0148","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2014.12.009"},{"key":"cit0149","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1717-8"},{"key":"cit0150","doi-asserted-by":"crossref","unstructured":"He Q, Jiang X, Zhou X, et al. Targeting cancers through TCR-peptide\/MHC interactions. J Hematol Oncol.\u00a02019;12(1):1\u201317.","DOI":"10.1186\/s13045-019-0812-8"},{"key":"cit0151","doi-asserted-by":"publisher","DOI":"10.1097\/PPO.0000000000000240"},{"key":"cit0152","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2009.12.004"},{"key":"cit0153","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-018-2484-0"},{"key":"cit0154","volume":"2020","author":"Zhang Q","year":"2020","journal-title":"CAR-T Cell Therapy in Cancer: Tribulations and Road Ahead"},{"key":"cit0155","doi-asserted-by":"publisher","DOI":"10.1097\/CJI.0000000000000260"},{"key":"cit0156","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-018-0672-7"},{"issue":"7","key":"cit0157","first-page":"1165","volume":"121","author":"Haso W","year":"2013","journal-title":"Blood, the Journal of the American Society of Hematology"},{"key":"cit0158","doi-asserted-by":"publisher","DOI":"10.1097\/CJI.0000000000000018"},{"key":"cit0159","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20112764"},{"key":"cit0160","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-2218"},{"key":"cit0161","doi-asserted-by":"crossref","unstructured":"Harrer DC, D\u00f6rrie J, Schaft N. CSPG4 as Target for CAR-T-Cell Therapy of Various Tumor Entities\u2013Merits and Challenges. Int J Mol Sci. 2019;20(23):5942.","DOI":"10.3390\/ijms20235942"},{"key":"cit0162","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-3197"},{"key":"cit0163","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-18-3158"},{"key":"cit0164","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-017-0548-2"},{"key":"cit0165","doi-asserted-by":"publisher","DOI":"10.1002\/cncy.20032"},{"key":"cit0166","doi-asserted-by":"publisher","DOI":"10.1111\/cup.12322"},{"key":"cit0167","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0749.2001.140309.x"},{"key":"cit0168","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2017.03.002"},{"key":"cit0169","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-23765-3"},{"key":"cit0170","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-08-802926"},{"key":"cit0171","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1701155"},{"key":"cit0172","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2018.03.001"},{"key":"cit0173","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-015-1767-4"},{"key":"cit0174","doi-asserted-by":"publisher","DOI":"10.1172\/JCI43490"},{"key":"cit0175","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-12-3913"},{"key":"cit0176","unstructured":"https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT01218867. 2020 December, 20"},{"key":"cit0177","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2016.63"},{"key":"cit0178","unstructured":"https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT02107963. December 20, 2020 [updated 2020 Dec 20]."},{"key":"cit0179","unstructured":"https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT02482532. December 20, 2020."},{"key":"cit0180","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-17-0538"},{"key":"cit0181","unstructured":"https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT03635632. December 20, 2020."},{"key":"cit0182","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nox116"},{"key":"cit0183","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2018.01.024"},{"key":"cit0184","doi-asserted-by":"crossref","unstructured":"Yang M, Tang X, Zhang Z, et al. Tandem CAR-T cells targeting CD70 and B7-H3 exhibit potent preclinical activity against multiple solid tumors. 2020;10(17):7622.","DOI":"10.7150\/thno.43991"},{"key":"cit0185","unstructured":"https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT02830724. December 20, 2020."},{"key":"cit0186","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019001463"},{"key":"cit0187","unstructured":"https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT04483778. December 20, 2020."},{"key":"cit0188","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2017.111"},{"key":"cit0189","unstructured":"https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT03893019. December 20, 2020."},{"key":"cit0190","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M115.707414"},{"key":"cit0191","unstructured":"https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT03649529. December 20, 2020"},{"key":"cit0192","doi-asserted-by":"crossref","unstructured":"Raza A, Merhi M, Inchakalody VP, et al. Unleashing the immune response to NY-ESO-1 cancer testis antigen as a potential target for cancer immunotherapy. J Transl Med. 2020;18(1):140.","DOI":"10.1186\/s12967-020-02306-y"},{"issue":"16023","key":"cit0193","volume":"3","author":"Maus MV","year":"2016","journal-title":"Molecular Therapy Oncolytics"},{"key":"cit0194","unstructured":"https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT03638206. December 20, 2020."},{"key":"cit0195","unstructured":"https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT04119024. December 20, 2020."},{"key":"cit0196","doi-asserted-by":"publisher","DOI":"10.1172\/JCI83416"},{"key":"cit0197","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-0319"},{"key":"cit0198","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20246223"},{"key":"cit0199","doi-asserted-by":"publisher","DOI":"10.1172\/JCI83092"},{"key":"cit0200","first-page":"1875","author":"Maus MV","year":"2016","journal-title":"AACR"},{"key":"cit0201","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.4195"},{"key":"cit0202","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-019-0721-y"},{"key":"cit0203","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2015.10.048"},{"key":"cit0204","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11081198"},{"key":"cit0205","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20143500"},{"key":"cit0206","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-1016"}],"container-title":["Expert Review of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/1744666X.2021.1880895","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T22:38:21Z","timestamp":1697668701000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/1744666X.2021.1880895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,31]]},"references-count":206,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3,4]]}},"alternative-id":["10.1080\/1744666X.2021.1880895"],"URL":"https:\/\/doi.org\/10.1080\/1744666x.2021.1880895","relation":{},"ISSN":["1744-666X","1744-8409"],"issn-type":[{"value":"1744-666X","type":"print"},{"value":"1744-8409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,31]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierm20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierm20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-11-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-01-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-01-31","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}